Formerly the senior VP of Science and Innovation at GlaxoSmithKline PLC, Perry Nisen brought both an experience-earned perspective and a set of goals when he took over as CEO of Sanford Burnham Prebys Medical Discovery Institute, mainly to help push the biopharmaceutical industry toward innovation and fresh thinking and away from a perceived focus on lower-risk business opportunities.
"One of my objectives for the institute, having spent 20 years in pharma on the other side of the table,...








